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Abstract
Background: Self-stigma is a result of internalizing negative 
stereotypes by the affected person. Research on self-stigma 
in substance use disorders (SUD) is still scarce, especially re-
garding the role of childhood trauma and subsequent post-
traumatic disorders. Objectives: The present study investi-
gated the progressive model of self-stigma in women with 
SUD and posttraumatic stress disorder (PTSD), and the pre-
dictive value of PTSD severity and childhood trauma experi-
ences on self-stigma. Method: In a cross-sectional study with 
343 women with SUD and PTSD, we used the Self-Stigma in 
Alcohol Dependency Scale, the Childhood Trauma Ques-
tionnaire (CTQ), the PTSD Symptom Scale Interview (PSS-I), 
and to control for SUD severity and depression, the Addic-
tion Severity Index Lite and the Beck Depression Inventory-II. 
Hierarchical regression analyses were conducted for each 
stage of self-stigma (aware-agree-apply-harm). Results: The 
interrelated successive stages of self-stigma were largely 
confirmed. In the regression models, no significant effects of 
the PSS-I- and the CTQ-scores were observed at any stage of 
self-stigma. Agreeing with negative stereotypes was solely 
predicted by younger age, applying these stereotypes to 
oneself was higher in women with younger age, higher de-
pression and SUD severity, and suffering from the applica-
tion (harm) was only predicted by depression. Conclusions: 
The progressive model of self-stigma could be confirmed in 
women with SUD and PTSD, but PTSD severity and child-
hood trauma did not directly affect this process. Self-stigma 
appears to be related to depression in a stronger way than 
PTSD is related to women with SUD and PTSD.
© 2019 S. Karger AG, Basel
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Introduction
Stigma affects thinking, behaviour and treatment out-
come in mental disorders [1]. A large body of research 
exists on stigma of mental illness and other health condi-
tions, for example, HIV/AIDS, but there is still lack of 
research on the stigma of addiction and the burden for 
people with substance use disorders (SUD) [2–4].
Stigma can be distinguished into public stigma, which 
refers to stereotypes, prejudices and discrimination in the 
general population towards the person concerned, and 
self-stigma, the process of internalizing those external 
negative views and applying the corresponding stereo-
types and prejudice to themselves [2].
The process of self-stigmatization in mental disorders 
[5–7] has been described in a model with 4 successive, 
interrelated stages. First, people start to be aware of the 
stereotypes prevalent in other people (stereotype aware-
ness, aware). In a second step, people personally agree 
with these stereotypes (stereotype agreement, agree). In a 
third step, they apply these stereotypes to themselves 
(self-concurrence, apply) and in the last step, this applica-
tion negatively impacts self-esteem and self-efficacy (self-
esteem decrement, harm). Thus, according to the model, 
accepting public stereotypes is a prerequisite for the de-
velopment of self-stigma.
Self-stigma was found to be negatively associated with 
self-esteem, hope and empowerment, and was positively 
associated with depression and symptom severity of men-
tal disorders [5, 8–12]. Furthermore, self-stigma nega-
tively affects treatment-seeking behaviour [13–18], qual-
ity of live [19–21] and recovery [22, 23]. However, not 
everyone, who perceives public stigma, internalizes these 
prejudices and suffers from low self-esteem. How each 
person reacts is still unclear and the conditions for inter-
nalizing stigmata are poorly understood.
Only a few studies investigated predictors of self-stig-
ma in SUD. A systematic review of Kulesza et al. [24] con-
cludes that self-stigma is positively associated with sub-
stance use frequency and drug and alcohol use severity. 
Among those individuals who use drugs, self-stigma is 
also related to higher depression and anxiety and lower 
psychological well-being. Schomerus et al. [7] found that 
among individuals who drink alcohol, self-stigma was 
negatively correlated with self-efficacy to refuse drinking. 
Results regarding sociodemographic variables are incon-
sistent, presumably due to the variance of the investigated 
samples and stigma types [24]. However, higher per-
ceived stigma towards people who use alcohol seems to 
be associated with a lower level of education. Moreover, 
there seems to be an association between perceived stig-
ma and age, but its direction is unclear due to the different 
investigated populations (adolescents vs. adults). In sum-
mary, self-stigma seems to be positively related to depres-
sion and anxiety in patients with SUD, and negatively re-
lated to psychological well-being and social inclusion 
[25].
Potential determinants of self-stigma in SUD, which 
have been poorly investigated so far, are traumatic experi-
ences, especially childhood abuse and neglect (CAN), and 
posttraumatic stress disorder (PTSD) [26]. Early trau-
matic experiences have been shown to be a robust predic-
tor of the development of SUD and are related to mal-
adaptive perceptions, beliefs and behaviours [27]. PTSD 
is one of the most frequent comorbid disorders in pa-
tients with SUD with a lifetime-prevalence of PTSD rang-
ing from 26 to 52% in SUD populations [28–30]. A recent 
study showed that self-stigma of alcohol dependence is 
stronger in persons with a history of childhood trauma 
[31]. Most results on the association between traumatic 
experiences and self-stigma are drawn from specific pop-
ulations like military or veteran samples [14–16, 32–38]. 
These studies indicate a significant association between 
self-stigma and help-seeking attitudes [14, 36], PTSD [16, 
33, 37], depression, functional impairment and alcohol 
problems [16]. However, findings on the contributing 
role of CAN and PTSD on self-stigma in people with SUD 
are lacking [39].
In this study, we investigated (1) whether the progres-
sive model of self-stigma is replicable in women with 
SUD and comorbid PTSD, and (2) whether self-stigma 
can be predicted by PTSD symptom severity and child-
hood trauma.
Methods
Setting and Procedure
The current study focuses on data assessed at baseline of a mul-
ticentre study on “Childhood Abuse and Neglect as a cause and 
consequence of Substance Abuse” (CANSAS-Study) [40], funded 
by the German Federal Ministry of Education and Research. The 
CANSAS-Study is a nationwide German research project which 
examined the associations between PTSD and SUD within 6 sub-
projects. The data presented here were assessed at baseline as part 
of a subproject on the cognitive-behavioural treatment for patients 
with PTSD and SUD (Project 2.A) [40]. In this project, female par-
ticipants meeting DSM-IV criteria for both SUD and PTSD were 
recruited between October 2012 and June 2015 with the help of 
counselling agencies at 5 participating study sites (Hamburg, Co-
logne, Essen, Bielefeld, and Hannover), newspaper advertisements 
and other means. Data collection was performed by clinical raters 
with at least a bachelor degree who received extensive training in 
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conducting clinical interviews and the administration of all the 
other assessments. Ongoing supervision and rater trainings were 
conducted to assure the validity of the data.
The study included female patients only due to higher preva-
lence rates of SUD and PTSD comorbidity in females (e.g., [27, 
41]), and the suggestion of some authors that trauma treatment 
should preferably be offered in gender-specific groups (e.g., [42]). 
In the present study, only baseline measures were analysed, irre-
spective of the following interventional study procedures.
Participants
Eligibility was defined according to the following criteria: (1) 
age 18–65, (2) female gender, (3) diagnosis of SUD according to 
DSM-IV with active use in the last 12 months, (4) diagnosis of at 
least partial PTSD according to DSM-IV (PTSD criteria A and B, 
and at least one of criteria C and D) [43]. Exclusion criteria were 
(1) current psychotic disorder, (2) acute suicidality, (3) serve cog-
nitive impairment and (4) intravenous drug use within 4 weeks 
before the start of study participation. All participants received 
extensive information about the study prior to participation and 
gave written informed consent. The study protocol was approved 
by the Ethics Committee of the Medical Association of Hamburg, 
Germany, and by each local committee of the other study sites. It 
was registered at the German Clinical Trials Register under the ID 
DRKS00004288.
Measures
Self-Stigma
To assess self-stigma, we used the Self-Stigma in Alcohol De-
pendence Scale (SSAD) [7]. This scale is an adaptation from the 
Self-Stigma of Mental Illness Scale [44]. According to the progres-
sive model of self-stigma [6, 7], the SSAD consists of the 4 scales 
“stereotype awareness” (aware), “stereotype agreement” (agree), 
“self-concurrence” (apply) and “self-esteem decrement” (harm). 
Each scale includes 16 statements, which are self-rated from 1 “do 
not agree at all” to 5 “strongly agree”. Sum scores for each scale 
range from 16 to 80. The reliability of the subscales was high in our 
sample with Cronbach’s alpha ranging from α = 0.85 (apply) to α = 
0.91 (aware).
Since the SSAD was developed for patients with alcohol depen-
dence, we changed the wording of the items to obtain a better fit 
for our sample (alcohol or drug use). To be specific, the words “al-
cohol problems” were changed to “addiction problems” (e.g., 
aware: “I think the public believes most persons with addiction 
problems are dangerous”; agree: “I think most people with addic-
tion problems are lazy”; apply: “Because I have an addiction prob-
lem, I am dangerous.”; harm: “I currently respect myself less be-
cause I am to blame for my problems.”). Therefore, all items of the 
scales aware, agree, and apply, and 2 of 16 items of the scale harm 
were adapted.
Substance Use Severity
The Addiction Severity Index Lite (ASI-Lite) [45] is an inter-
view which assesses 7 potential problem fields related to substance 
dependence. Composite scores can be calculated for each problem 
field and range from 0 to 1. The ASI-Lite has strong psychometric 
properties (e.g., [46]). For our analyses we used a combination of 
the 2 composite scores for alcohol and drug use respectively. We 
computed a single score for “SUD severity” based on the higher 
value of both composite scores.
PTSD Severity
The PTSD Symptom Scale Interview (PSS-I) [47] was used to 
assess the severity of PTSD symptoms. The PSS-I consists of 17 
items corresponding to the symptoms of PTSD symptom clusters 
B, C and D according to DSM-IV. The severity of each symptom 
is rated by the interviewer on a scale from 0 to 3 resulting in a sum 
score (range 0–51), with higher scores indicating higher PTSD 
symptom severity. The PSS-I has strong psychometric properties 
[47]. The reliability of the PSS-I was good within our sample 
(Cronbach’s α = 0.81).
Early Traumatic Experiences
The Childhood Trauma Questionnaire (CTQ) [48] covers 5 
possible types of early traumatic experiences. A total of 28 items 
on the scales emotional abuse, physical abuse, emotional neglect, 
physical neglect and sexual abuse are self-rated on a scale from 1 
“never true” to 5 “very often true”. Each of the 5 scales ranges from 
5 to 25 with higher scores indicating more severe traumatic experi-
ences. The CTQ showed good reliability in the general German 
population [49] and within our sample (Cronbach’s α  = 0.71 
[physical abuse] to Cronbach’s α = 0.96 [sexual abuse]).
Depressive Symptom Severity
The Beck’s Depression Inventory-II [50] is one of most com-
monly used self-report inventories for assessing the severity of de-
pressive symptoms. It consists of 21 questions about the emotion-
al state in the last 2 weeks. Each question is followed by 4 state-
ments that reflect the symptom severity ranging from 0 to 3. Sum 
scores range from 0 to 63 with higher scores indicating more severe 
depressive symptoms. A high reliability was given in our sample 
(Cronbach’s α = 0.91).
Diagnoses of SUD and PTSD
SUD and PTSD diagnoses were confirmed using the German 
research version of the Structured Clinical Interview for DSM-IV 
Disorders [51] at study baseline. Demographic information in-
cluding age, years of education, marital status and employment, 
and medical information including current or former treatment, 
was also obtained in the course of this interview. The baseline as-
sessment was conducted by trained clinical raters with at least a 
bachelor degree.
Statistical Analyses
Examining the Progressive Model of Self-Stigma
To investigate the progressive model of self-stigma, we first ex-
amined whether the SSAD scales differed overall. A repeated-mea-
sures ANOVA was conducted followed by paired t tests, which 
examined differences between the proximate scales. Moreover, we 
looked at inter-correlations to investigate whether each scale cor-
related most highly with its predecessor scale. Additionally, de-
scriptive analyses on self-stigma were conducted for the subgroups 
with those who used (1) alcohol only, (2) any other drugs but al-
cohol only, and (3) alcohol and drugs.
Predicting Self-Stigma by Early Traumatic Experiences and 
PTSD
We conducted multiple hierarchical regression analyses with 
each of the 4 SSAD scales as dependent variables and the measures 
of CAN and PTSD symptom severity as independent variables. We 
adjusted for demographic characteristics including age and educa-
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tion, depressive symptom severity and SUD severity, since prior 
studies have found an association between these variables and self-
stigma. Although results on the association with age and education 
are sparse, also with regard to the direction between age and self-
stigma heterogeneous, we included age and education (dummy 
coded with low educational level as the reference category) in the 
first step of the hierarchical regression. In the second and third 
steps, we included depressiveness and SUD severity as further con-
trol variables. The order of entry of the control variables was based 
on empirical and theoretical assumptions: with regard to their 
temporally determined priority we assumed that age and educa-
tion would precede depressiveness and SUD severity in most cases. 
Current PTSD symptom severity (as measured by the PSS-I) and 
CAN (as measured by the 5 scales of the CTQ) were the measures 
of interest, and thus, included in the fourth and fifth step, respec-
tively, in order to investigate the incremental amount of explained 
variance in self-stigma. The assumptions for hierarchical regres-
sion analyses such as normality distribution of residuals, homosce-
dasticity and no multicollinearity of predictors were tested and 
fulfilled.
Results
Participants
A total of 610 women were assessed for eligibility, of 
which 234 could not be included into the trial, mainly 
because they did not fulfil the inclusion criteria (n = 123). 
Further reasons were as follows: declination to partici-
pate (n = 47), lost to baseline assessment (n = 34), and 
other reasons, for example, incomplete screening or im-
prisonment (n = 30). Another 33 women discontinued 
the baseline assessment, resulting in a final study sample 
of n  = 343 women who completed baseline measure-
ments.
Study Sample
Sample characteristics are shown in Table 1. The wom-
en were on average 40.9 years old (SD 11.4). The major-
ity were unemployed (67.1%) and single (83.7%). The 
mean depressive symptom severity was 27.8 (SD 12.0), 
which indicates moderate depression.
More than half of all women abused or were depen-
dent on both alcohol and drugs (53.9%). Alcohol, canna-
bis and sedatives were the most frequently abused sub-
stances. Nearly every participant (94.5%) had at least one 
substance dependence diagnosis, whereas the remaining 
5.5% met the criteria for substance abuse. SUD severity 
was moderate (M 0.34, SD 0.25). For a full PTSD, 75.2% 
of all women met criteria and the mean PTSD symptom 
severity was M 27.3 (SD 9.7). The highest scores were re-
ported for the CTQ subscales emotional abuse (M 17.4, 
SD 5.5), and emotional neglect (M 17.9, SD 5.3). Most of 
the women (n  = 315; 92%) either have received prior 
treatment or were currently undergoing treatment for 
SUD and/or PTSD.
Examining the Progressive Model of Self-Stigma
Within the total sample, sum scores were the highest 
for the SSAD subscale aware (M 60.8, SD 12.3) and de-
creased gradually for the following subscales agree (M 
37.8, SD 10.6), apply (M 31.1, SD 10.1) and harm (M 31.0, 
SD 10.5; Table 2). Subgroup analyses for the “alcohol 
only” (n = 108) and “other drugs only” (n = 50) groups 
showed similar results, except for the agree scale, for 
which the subgroup “other drugs only” (M 39.5; SD 9.9) 
showed higher scores than the subgroup “alcohol only” 
(M 36.4; SD 10.1).
The scales differed from one another according to the 
repeated-measures ANOVA (F [2.255, 759.87] = 886.58, 
p  < 0.001, ηp2  = 0.73; Huynh-Feldt corrected). Single 
paired t test with Holm’s sequential Bonferroni correc-
tion resulted in significant differences between the scales 
aware and agree (t [340] = 30.35, p < 0.001, Cohen’s d = 
2.00), and between the scales agree and apply (t [339] = 
11.66, p < 0.001, Cohen’s d = 0.64). However, apply and 
harm did not significantly differ from each other (t [337] = 
0.33, p = 0.74). Table 3 shows the inter-correlations of the 
4 scales. All correlations of proximate scales are higher 
than those of distal scales. The highest correlation was 
found for apply and harm (r = 0.78; p < 0.01), the lowest 
was found for aware and harm (r = 0.18; p< 0.01).
Predicting Self-Stigma by CAN and PTSD Severity
Table 4 shows the results of 4 hierarchical multiple re-
gression analyses that were conducted for each of the 4 
SSAD scales as dependent variables.
Stereotype Awareness (Aware)
Depression was correlated with aware (r = 0.11, p = 
0.019) but did not statistically significantly contribute to 
the prediction in the final model (β = 0.12, p = 0.068). The 
final model overall explained 3% of the variance in aware 
(R2 = 0.03).
Stereotype Agreement (Agree)
In the second regression model, younger age corre-
lated in a statistically significant manner with agree (r = 
–0.15, p = 0.002) and was the sole significant predictor of 
agree in the regression model (β = –0.15, p = 0.014). Tak-
en together with years of education, a unique proportion 
of variance in the agree scale was explained (∆R2 = 0.03, 
p = 0.029). PTSD symptom severity was also correlated 
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Table 1. Demographic and clinical sample characteristics
Total sample (n = 343)
Demographic characteristics
Age , years, mean (SD, range) 40.94 (11.37, 19–65)
Years of education, n (%)
≤9 years 114 (33.3)
10 years (high school diploma) 114 (33.2)
≥13 years (Matura or university degree) 115 (33.5)
Marital status, n (%)
Single 287 (83.7)
Married, cohabiting 34 (9.9)
Married, living separately 22 (6.4)
Employment status, n (%)
Unemployed 230 (67.1)
Employed 112 (32.7)
Depressive symptoms
Depressive symptom severity (BDI-II), mean (SD, range) 27.82 (12.03, 0–58)
Substance use 
Diagnosis1, n (%)
Substance use: Exclusively alcohol 108 (31.5)
Substance use: Exclusively other drugs 50 (14.6)
Substance use: Both alcohol and other drugs 185 (53.9)
Substances use disorder, n (%)
Alcohol 293 (85.4)
Sedatives 106 (30.9)
Cannabis 165 (48.1)
Stimulants 96 (28.0)
Opiates 73 (21.3)
Cocaine 97 (28.3)
Hallucinogens 61 (17.8)
Polytoxicomania 96 (28.0)
Others 21 (6.1)
Consumption of any substances in the last 30 days (ASI-Lite), n (%)
Total 270 (78.7)
Alcohol 225 (65.6)
Drugs 153 (44.6)
Days of consumption in the last 30 days (ASI-Lite), mean (SD, range)
Alcohol 8.34 (10.08, 0–30) 
Drugs2 8.09 (12.04, 0–30)
Alcohol and Drug problem severity (ASI-Lite), mean (SD, range) 0.34 (0.25, 0–0.96)
PTSD and early traumatic experiences
Diagnosis, n (%)
Full PTSD 258 (75.2)
Subsyndromal PTSD 85 (24.8)
PTSD symptom severity (PSS-I), mean (SD, range) 27.30 (9.71, 0–49)
Early traumatic experiences (CTQ), mean (SD, range)
Emotional abuse 17.36 (5.52, 5–25)
Physical abuse 11.58 (5.78, 5–25)
Sexual abuse 13.60 (6.93, 5–25)
Emotional neglect 17.87 (5.31, 5–25)
Physical neglect 11.43 (4.46, 5–24)
1 Substance use disorders include abuse or dependence of substances.
2 The drug category was composited from the single categories heroin, methadone, opiates, psychotropic drugs, cocaine, am-
phetamines, cannabis, hallucinogens, inhalants, and other.
BDI-II, beck depression inventory-II; ASI-Lite, addiction severity index lite; PTSD, posttraumatic stress disorder; PSS-I, PTSD 
symptom scale interview; CTQ, childhood trauma questionnaire.
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with the agree scale (r = 0.10; p = 0.04) but did not con-
tribute to the model. The final model explained 4% of the 
variance in agree (R2 = 0.04).
Self-Concurrence (Apply)
Statistically significant bivariate associations with the 
apply scale were found for younger age (r = –0.13, p = 
0.01), higher depression (r  = 0.31, p  < 0.001), a higher 
SUD severity (r = 0.14, p = 0.007), more severe early emo-
tional abuse experiences (r = 0.13, p = 0.008) and more 
severe PTSD symptoms (r = 0.16, p = 0.002). In the regres-
sion model, age (β = –0.14, p = 0.009), depression (β = 
0.28, p < 0.001) and SUD severity (β = 0.11, p = 0.039) 
were predictive of the outcome in the final model and 
moreover, each explained a unique proportion of vari-
ance (age and education: ∆R2 = 0.03, p = 0.03; depression: 
∆R2 = 0.09, p < 0.001; SUD severity: ∆R2 = 0.01, p = 0.04). 
The final model explained 14% of the variance in apply 
(R2 = 0.14).
Self-Esteem Decrement (Harm)
The correlations with the harm subscale were similar 
to those found for the apply scale. Depression (r = 0.46, 
p < 0.001), SUD severity (r = 0.15, p = 0.002), early emo-
tional abuse (r = 0.16, p = 0.002) and PTSD symptoms (r = 
0.23, p < 0.001) were also correlated with harm. More-
over, early emotional neglect (r = 0.12, p = 0.016), and 
early physical neglect (r = 0.11, p = 0.027) were associated 
with harm in the univariate analyses. Age and education-
al level were not correlated with harm. However, in the 
regression analysis, depression was the sole predictor of 
harm in the final model (β = 0.42, p < 0.001) and contrib-
uted a unique proportion of explained variance of ∆R2 = 
0.20 (p < 0.001). The final model explained 24% of vari-
ance in harm (R2 = 0.24).
Given the heterogeneity with regard to the links be-
tween age and education on self-stigma, respectively, we 
repeated the regression analyses without age and educa-
tion. Except for minor changes in regression coefficients, 
the results remained the same.
Discussion
The present study is the first to investigate the progres-
sive model of self-stigma in women with SUD and co-
morbid PTSD. Additionally, we examined the predictive 
value of PTSD severity and childhood trauma experienc-
es on the different stages of self-stigma.
The progressive model of self-stigma hypothesizes 
that each of the 4 stages is the precondition for the follow-
ing stage. The scores of the 4 scales decreased continu-
ously in our sample, except apply and harm, which did 
not differ significantly. Both scales had a similarly high 
score, comparable with the score of apply in an alcohol-
dependent sample [7]. Moreover, in our sample, the score 
of the aware subscale (M 60.8, SD 12.3) was significantly 
higher compared to that of patients with alcohol depen-
dence (M 46.5; 1-sample t test: t [340] = 21.47, p < 0.001) 
[7]. Subgroup analyses in our study have shown that both 
groups, “other drugs only” and “alcohol only”, had simi-
lar high scores. However, the scores of the agree subscale 
Table 2. Self-stigma: SSAD scales (total sample and substance use subsamples)
SSAD scale Total sample (n = 343), 
mean (SD, range)
Alcohol only (n = 108), 
mean (SD, range)
Other drugs only (n = 50), 
mean (SD, range)
Alcohol and drugs (n = 185), 
mean (SD, range)
Aware 60.83 (12.33, 20–80) 60.49 (11.60, 25–80) 59.90 (13.37, 25–80) 61.29 (12.49, 20–80)
Agree 37.80 (10.57, 16–76) 36.39 (10.07, 16–64) 39.52 (9.94, 19–66) 38.15 (10.97, 18–76)
Apply 31.13 (10.06, 16–69) 29.35 (8.66, 16–64) 30.27 (10.20, 16–69) 32.39 (10.64, 16–69)
Harm 30.96 (10.53, 16–69) 29.11 (9.44, 16–62) 28.91 (10.37, 16–58) 32.58 (10.94, 16–69)
SSAD, self-stigma in alcohol-dependence scale.
Table 3. Inter-correlations of the 4 SSAD scales
SSAD
Aware Agree Apply Harm
SSAD
Aware 1
Agree 0.26** 1
Apply 0.22** 0.48** 1
Harm 0.18** 0.34** 0.78** 1** p < 0.01.
SSAD, self-stigma in alcohol-dependence scale.
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were the highest in the “other drugs only” group, indicat-
ing that women with drug use seem to agree more with 
public prejudices regarding their conditions as compared 
to individuals with alcohol dependence only [52].
The total correlation pattern of the self-stigma scales, 
however, was consistent with that of the proposed model 
[5, 7] and the interrelated successive stages of self-stigma 
were largely replicated in our sample of women with SUD 
and comorbid PTSD.
The second research question investigated the role of 
CAN and PTSD symptom severity in the process of self-
stigma, while controlling for demographic and clinical 
characteristics. The severity of PTSD symptoms and the 
extent of early traumatic experiences did not have any 
significant effect on either stage of self-stigma. In a sam-
ple of alcohol-dependent persons, Stolzenburg et al. [31] 
found childhood trauma to be significantly associated 
with the self-stigma stages agree, apply and harm. The 
lack of effect may be due to the methodological shortcom-
ing of the reduced variance in PTSD symptoms and early 
traumatic experiences, since both were inclusion criteria 
for the study. Our results suggested that agreeing with 
negative stereotypes was solely predicted by younger age, 
applying these stereotypes to oneself was predicted by 
younger age, higher depression, and SUD severity, where-
as suffering from the application of the stereotypes (harm) 
was solely predicted by depression.
Being aware of negative stereotypes was not signifi-
cantly predicted by any of the examined variables. Al-
though depression was positively associated with the 
aware scale in the univariate correlation, this relation-
ship did not reach statistical significance in the final 
model.
Although results on the association between age and 
self-stigma in other mental disorders are inconsistent, 
there seems to be a tendency towards younger age being 
related to higher internalized stigma [8]. In our sample, 
being aware and agreeing with stereotypes was predicted 
by younger age. In contrast to other studies where this 
relationship was found [53], our sample had a relatively 
high mean age (M 40.9). Thus, even in the adult popula-
tion, younger age seems be a risk factor for internalizing 
negative stereotypes towards alcohol and drug use. Based 
on the results of a large European study, Krajewski et al. 
Table 4. Prediction of SSAD scales
Step Predictors SSAD aware SSAD agree SSAD apply SSAD harm
run-adj. β ∆R² run-adj. β ∆R² run-adj. β ∆R² run-adj. β ∆R²
Step 1 Age, years –0.063 –0.055 0.007 –0.153** –0.148* 0.027* –0.126** –0.141** 0.027* –0.083 –0.090 0.022
Education (10 years) 0.047 0.045 0.038 <0.001 0.102 0.090 0.093 0.104
Education (≥13 years) –0.009 0.013 –0.068 –0.068 –0.040 0.013 0.016 0.065
Step 2 Depression (BDI–II) 0.113* 0 121 0.012* 0.075 0.021 0.005 0.309*** 0.282*** 0.090*** 0.456*** 0.421*** 0.200***
Step 3 SUD severity (ASI–Lite) –0.006 –0.016 <0.001 0.020 0.041 0.002 0.135** 0.112* 0.011* 0.154** 0.092 0.007
Step 4 Early traumatic experience (CTQ)
Emotional abuse –0.088 0.152 0.010 0.048 0.088 0.004 0.133** 0.104 0.013 0.157** 0.122 0.009
Physical abuse 0.006 –0.039 –0.007 –0.048 0.077 0.041 0.017 –0.063
Sexual abuse –0.007 –0.041 0.009 –0.017 –0.005 –0.082 0.043 –0.038
Emotional neglect 0.027 –0.065 0.007 –0.019 0.080 –0.082 0.117* –0.053
Physical neglect 0.025 –0.001 –0.006 –0.021 0.080 0.045 0.106* 0.048
Step 5 PTSD symptoms (PSS-I) 0.036 –0.036 0.001 0.098* 0.070 0.004 0.158** –0.013 <0.001 0.229*** –0.009 <0.001
R² (adjust. R²) 0.030 (0.003) 0.041 (0.008) 0.141 (0.112) 0.238 (0.212)
F(11, 322) = 0.897 F(11,322) = 1.251 F(11,321) = 4.804*** F(11,320) = 9.074**** p < 0.05.** p < 0.01.*** p < 0.001.
Due to list wise deletion, regression analyses were performed with n = 334 for SSAD aware, SSAD agree, n = 333 for SSAD apply and n = 332 for SSAD harm. 
Education was dummy-coded with “≤9 years of education” as the reference category.
SSAD, self-stigma in alcohol dependence scale; BDI-II, beck’s depression inventory; SUD, substance use disorder; ASI, addiction severity index; CTQ,  child-
hood trauma questionnaire; PTSD, posttraumatic stress disorder; PSS-I, PTSD symptom scale interview; run-adj., unadjusted bivariate correlations; β, standardized 
regression coefficients; ∆R², incremental proportion of variance explained by each regression step.
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[53, 54] hypothesized an inverse u-shaped function be-
tween age and self-stigma.
Results on the predictive value of further demograph-
ic measures on stigma are also inconsistent [24]. While 
lower educational level was associated with higher stigma 
in patients with depression [55], higher education was 
found to be a risk factor for self-stigma in patients with 
SUD [56]. In our sample, no significant association was 
found for educational level.
Depressiveness was the strongest predictor of apply 
and harm, consistent with the finding of a previous re-
search in individuals with SUD or PTSD (e.g., [16, 24, 
57]). Core features of depression are low self-esteem and 
diminished hope [58]; thus, as described by Corrigan et 
al. [6], “one of the difficulties (…) is sorting out the effects 
of self-stigma from those of depression because symp-
toms of depression fundamentally lead to diminished 
self-esteem”. Therefore, to distinguish the effects of de-
pression from those of self-stigma on self-esteem and 
hope, studies investigating all 3 constructs would be 
needed.
Prior research on self-stigma in individuals with 
traumatic experiences was mostly carried out in mili-
tary samples. Patients with PTSD showed significantly 
higher internalized stigma scores than those without 
PTSD [33]. Self-stigma related to seeking treatment and 
the perception of being stigmatized by others correlated 
positively with depression, PTSD and functional im-
pairment, while the latter was also positively correlated 
with alcohol problems [16]. These results show the po-
tential impact of PTSD on self-stigma, although such 
effects were not observed in our study after controlling 
for depressive symptoms. Severity of PTSD symptoms, 
but also emotional abuse and neglect in childhood, 
were positively associated with self-stigma (apply and 
harm) in the univariate analyses, but when we con-
trolled for depression, these associations were no longer 
observed. Depression may thus mediate the effect be-
tween PTSD symptoms/CAN and self-stigma, that is, 
the risk to develop self-stigmatizing beliefs might be in-
creased only when people with CAN and PTSD experi-
ence depressive symptoms. A mediating effect of de-
pression for harm was shown in a recent study [31]. 
Another explanation for the missing relationship be-
tween PTSD and self-stigma in our multivariate models 
might be that our focus was on PTSD severity but not 
PTSD diagnosis per se. All patients in our sample were 
affected by PTSD, which might have reduced the ex-
planatory value of this variable. The meaning of trau-
matic experiences and its consequences for stigma 
should be further investigated in future studies in order 
to understand the complexity of conditions and main-
tenance of maladaptive beliefs.
One limitation of our study was the cross-sectional de-
sign, which limits our ability to draw causal inferences. 
This is of particular relevance for the association between 
depression and self-stigma. Depressive symptoms might 
lead to a higher self-stigma, as well as vice versa, and lon-
gitudinal studies are needed to examine the nature of the 
relationship between these variables.
A second limitation is a potential selection bias due to 
our study sample. All participants were recruited for an 
RCT, which investigated the effectiveness of a cognitive 
behavioural treatment for patients with PTSD and SUD. 
Nearly all women have had prior treatment or were cur-
rently in treatment. Therefore, all participants in this 
study were, to a certain extent, motivated for treatment. 
Due to the results on the negative association of self-stig-
ma and treatment seeking behaviour, it could be argued 
that our sample could be biased regarding self-stigma and 
could have expressed lower stigmatizing beliefs than pa-
tients with SUD and PTSD not seeking treatment. How-
ever, the mean scores of the SSAD scales were rather high 
in our sample. The subgroup of women who had drug 
abuse or dependence was heterogeneous regarding the 
used substance, including legal and illegal drugs with 
varying degrees of social acceptance (Table 1). People 
with intravenous drug use within the past 4 weeks were 
excluded from the study. Thus, results on this subgroup 
are difficult to interpret and limited regarding generaliz-
ability.
Finally, the SSAD was constructed and validated for 
people with alcohol problems. For the purpose of our 
study, we had to adapt the wording of many items, but the 
proposed progressive model of self-stigmatization was 
largely confirmed in our sample, suggesting its validity 
also for patients with other SUD problems. While in this 
study we investigated SUD-related stigmatization in the 
specific group of SUD patients with comorbid PTSD, fu-
ture research should consider to widen this focus and de-
velop instruments that cover potential effects of both 
sources of stigmatization, SUD and PTSD.
In summary, the progressive model of self-stigma 
could be confirmed in our sample of women with SUD 
and comorbid PTSD. Furthermore, our findings suggest 
that age, SUD severity and especially depression could be 
important variables when trying to identify patients with 
SUD and PTSD at increased risk for self-stigmatizing at-
titudes and the psychological consequences related to 
them. Being aware of the mechanisms and processes of 
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self-stigma in this specific severely affected population 
can help clinicians to address these maladaptive beliefs 
early on in therapy. Clinicians should give attention to 
patients’ attitudes towards alcohol-and drug-related ste-
reotypes, especially in young women with high depres-
siveness. Interventions to reduce self-stigma should be 
developed and investigated in these highly impaired SUD 
patients.
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